Company intelligence / Profile preview

MicroMGx

Chicago, Illinois, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

MicroMGx's lead natural product, MGX 1001, is a new mechanism of action herbicide co-discovered by co-founder Bill Metcalf and Alexander Polidore. The compound was submitted for patent protection in 2020 and is currently in an exclusive discovery agreement with a top agricultural company in preparation for licensing negotiations.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Agriculture & AgTech

Partnerships

Corteva AgriscienceElanco Animal Health

Beyond the preview

Go deeper on MicroMGx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroMGx.

Explore the full profile